bpc-157 clinical trial humans randomized If worked as well as the internet says it does… …we'd probably have high quality human trials by now. Instead we have... Lots of rat studies. Lots of podcasts. Lots of Frontiers | Pharmacokinetics, distribution, metabolism,
Description
No data exists on developmental effects, and cell proliferating properties raise theoretical concerns
Effects of the novel long-acting GLP-1 agonist, albiglutide, on cardiac function, cardiac metabolism, and exercise capacity in patients with chronic heart failure and reduced ejection fraction
Inductively coupled plasma mass spectrometry (ICP-MS) or atomic absorption spectroscopy (AAS) should confirm a 1:1 Cu:peptide stoichiometry
to suggest BPC 157 is safe for use in humans
More about the science here.
